Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington’s disease transgenic R6/2 (160 CAG) mice
Open Access
- 17 February 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep42797
Abstract
Whereas Huntington’s disease (HD) is unequivocally a neurological disorder, a critical mass of emerging studies highlights the occurrence of peripheral pathology like cardiovascular defects in both animal models and humans. The overt impairment in cardiac function is normally expected to be associated with peripheral vascular dysfunction, however whether this assumption is reasonable or not in HD is still unknown. In this study we functionally characterized the vascular system in R6/2 mouse model (line 160 CAG), which recapitulates several features of human pathology including cardiac disease. Vascular reactivity in different arterial districts was determined by wire myography in symptomatic R6/2 mice and age-matched wild type (WT) littermates. Disease stage was assessed by using well-validated behavioural tests like rotarod and horizontal ladder task. Surprisingly, no signs of vascular dysfunction were detectable in symptomatic mice and no link with motor phenotype was found.Keywords
This publication has 31 references indexed in Scilit:
- Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's diseaseThe Journal of Physiology, 2012
- Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease miceProceedings of the National Academy of Sciences, 2012
- A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's diseaseJournal of Neurophysiology, 2012
- Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's diseaseNeurobiology of Disease, 2011
- Autonomic symptoms in patients and pre‐manifest mutation carriers of Huntington’s diseaseEuropean Journal of Neurology, 2010
- Autonomic dysfunction in presymptomatic and early symptomatic Huntington’s diseaseActa Neurologica Scandinavica, 2009
- Cardiac dysfunction in the R6/2 mouse model of Huntington’s diseaseNeurobiology of Disease, 2007
- Measurement of Mutational Flow Implies Both a High New-Mutation Rate for Huntington Disease and Substantial Underascertainment of Late-Onset CasesThe American Journal of Human Genetics, 2001
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Huntington's disease mortality in the United StatesNeurology, 1988